Invasive Mammary Carcinoma
A 46-year-old patient presents for routine screening mammography. Family history of breast cancer consists of a maternal aunt and grandmother.
CLINICAL HISTORY
A 46-year-old patient presents for routine screening mammography. Family history of breast cancer consists of a maternal aunt and grandmother.
FINDINGS
Digital mammography reveals an irregular 2.2cm mass in the left breast, approximately 10cm from the nipple (Figure 1a-b). The mass persists on the magnification view (Figure 1c).
(Figure 1a)
(Figure 1b)
(Figure 1c)
On physical exam, no discrete mass is palpated. Ultrasound demonstrates an irregular hypoechoic mass within the left 3:30 area measuring up to 1.4cm (Figure 2).
(Figure 2)
MRI imaging performed for extent of disease demonstrates the known carcinoma measuring 2.0 x 2.2cm in the left breast (Figure 3a-b).
(Figure 3a)
(Figure 3b)
DIAGNOSIS
Vacuum assisted stereotactic needle core biopsy of the left breast 3:30 mass reveals invasive mammary carcinoma.
DISCUSSION
This case demonstrates the benefit of screening mammography in a premenopausal woman. This was a large lesion that was not palpable and was not found by the patient or her physician. This was identified on the screening mammogram which initiated additional evaluation with magnification views, ultrasound, stereotactic biopsy, and subsequent breast MRI.
Stamatia Destounis, MD, is managing partner and a radiologist at Elizabeth Wende Breast Care in Rochester, NY.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
